The healthcare data firm highlights a 60% pipeline expansion alongside double-digit contract value growth in its latest quarter.
NRC Health announced an expected effective tax rate of approximately 40% for the second half of the year during its Q2 2026 earnings call. The company reported an 11% year-over-year increase in total recurring contract value (TRCV), reflecting strong execution in the quarter.
Management noted diversified growth across its business segments, with TRCV growth driven by new client acquisitions and expanded contracts. The company also highlighted a 60% expansion in its sales pipeline, signaling potential future revenue opportunities.
No immediate market reaction was disclosed in the call, though the tax rate projection and pipeline growth may influence investor sentiment.